Gene · 665
Papers2,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,878
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Convergent and divergent mechanisms of peroxisomal and mitochondrial division. | J Cell Biol | 2023 | 37530713 | PubTator, text mining | PubMed |
| Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. | Bioinform Biol Insights | 2023 | 37529485 | PubTator, text mining | PubMed |
| Role of mitochondrial alterations in human cancer progression and cancer immunity. | J Biomed Sci | 2023 | 37525297 | PubTator, text mining | PubMed |
| PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. | Front Oncol | 2023 | 37519797 | PubTator, text mining | PubMed |
| Pluripotency-Associated microRNAs in Early Vertebrate Embryos and Stem Cells. | Genes (Basel) | 2023 | 37510338 | PubTator, text mining | PubMed |
The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases. | Cells | 2023 | 37508561 | PubTator, text mining | PubMed |
| Diagnostic Value and Prognostic Significance of Nucleated Red Blood Cells (NRBCs) in Selected Medical Conditions. | Cells | 2023 | 37508482 | PubTator, text mining | PubMed |
| Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs. | Antioxidants (Basel) | 2023 | 37507917 | PubTator, text mining | PubMed |
| Antioxidative Role of Heterophagy, Autophagy, and Mitophagy in the Retina and Their Association with the Age-Related Macular Degeneration (AMD) Etiopathogenesis. | Antioxidants (Basel) | 2023 | 37507908 | PubTator, text mining | PubMed |
| Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. | J Transl Med | 2023 | 37507803 | PubTator, text mining | PubMed |
| Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review. | Heliyon | 2023 | 37496898 | PubTator, text mining | PubMed |
| Hyperubiquitylation of DNA helicase RECQL4 by E3 ligase MITOL prevents mitochondrial entry and potentiates mitophagy. | J Biol Chem | 2023 | 37495109 | PubTator, text mining | PubMed |
| Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. | J Biol Chem | 2023 | 37481209 | PubTator, text mining | PubMed |
| Integrative profiling of extrachromosomal circular DNA in placenta and maternal plasma provides insights into the biology of fetal growth restriction and reveals potential biomarkers. | Front Genet | 2023 | 37476414 | PubTator, text mining | PubMed |
| Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia. | Front Oncol | 2023 | 37469404 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction and mitophagy: crucial players in burn trauma and wound healing. | Burns Trauma | 2023 | 37465279 | PubTator, text mining | PubMed |
| The mitophagy receptor NIX induces vIRF-1 oligomerization and interaction with GABARAPL1 for the promotion of HHV-8 reactivation-induced mitophagy. | PLoS Pathog | 2023 | 37459327 | PubTator, text mining | PubMed |
| Mitochondria in colorectal cancer stem cells - a target in drug resistance. | Cancer Drug Resist | 2023 | 37457136 | PubTator, text mining | PubMed |
| Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment. | Front Pharmacol | 2023 | 37456742 | PubTator, text mining | PubMed |
| FDX1 regulates cellular protein lipoylation through direct binding to LIAS. | J Biol Chem | 2023 | 37453661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/665/papers?page=19